News
🌏 NMPALatest pharmaceutical news, drug approvals, and NMPA regulatory updates
Showing 1–12 of 246 articles
Quick answer
NovaPharmaNews Asia-Pacific Region news feed tracks 246 published stories — NMPA regulatory actions, clinical trial readouts, M&A, and commercial milestones for pharma BD, investors, and market access teams. Browse by topic, explore linked company and drug profiles, or switch to analysis for deeper commentary.
Blood pressure and ischemic stroke risk in dementia: nationwide cohort findings
PMDA approves ENHERTU for HER2-low breast cancer in Japan
TGA Australia drug approval pharmaceutical: what the regulator is
Areas with Risk of Dengue: CDC map, criteria, and global reach
Fosun Pharma and AriBio Forge Alzheimer's Option Agreement: Deal Intelligence
PMDA Regulatory Updates: New Orphan Drug Portal and ASEAN Symposium Open
NMPA China FDA Drug Approval: 2026 Pathways, Timelines & Impact
Vietnam and India Reshape Middle Power Diplomacy: Market Analysis for Pharma
NMPA Drug Approvals Surge in 2025: Record 61 First Global Approvals Signal Accelerated Market Access
Building a Smarter Medical Devices Ecosystem in India: Regulatory Updates
Cell and Gene Therapy Approvals in China: Latest Regulatory Updates
A Decade of AI Medical Device Regulation: Key Updates for Pharma
Frequently asked questions
What does the regional news feed cover?
Breaking pharmaceutical news for the selected edition — regulatory actions, clinical readouts, corporate announcements, partnerships, and market-moving signals. Each story links to company profiles, drug INN pages, trials, and events where entities are tagged.
How is news different from analysis on NovaPharmaNews?
News covers timely regulatory and commercial developments. Analysis & Commentary provides in-depth opinion, market context, and expert interpretation. Use the content-type chips above to switch between latest news and analysis hubs.
How often is this feed updated?
New articles publish continuously as FDA, EMA, PMDA, NMPA, and other agency signals break. Subscribe to the weekly digest in the sidebar for a curated Monday roundup.